Author | Lightnews

Reposted by Navneet Majhail

Navneet Majhail @bldcancerdoc.bsky.social · 23d

I am walking at Blood Cancer United Nashville's Light The Night Walk on October 23rd. I will be walking for our patients who are an inspiration to me and our team at Sarah Cannon Cancer Network Transplant and Cellular Therapy Program at TriStar Centennial.

pages.lls.org/ltn/tn/MidTN...

Navneet's Light The Night Fundraiser

Light The Night At Blood Cancer United's, formerly LLS, Light The Night we gather as a community to celebrate, honor, and remember those touched by blood cancers. Friends, families, schools, corporate...

pages.lls.org

1 1

Navneet Majhail @bldcancerdoc.bsky.social · 23d

I am walking at Blood Cancer United Nashville's Light The Night Walk on October 23rd. I will be walking for our patients who are an inspiration to me and our team at Sarah Cannon Cancer Network Transplant and Cellular Therapy Program at TriStar Centennial.

pages.lls.org/ltn/tn/MidTN...

Navneet's Light The Night Fundraiser

Light The Night At Blood Cancer United's, formerly LLS, Light The Night we gather as a community to celebrate, honor, and remember those touched by blood cancers. Friends, families, schools, corporate...

pages.lls.org

1 1

Navneet Majhail @bldcancerdoc.bsky.social · 27d

It was great to catch up with fellow Cleveland Clinic expat Nate Pennell during his recent visit to Sarah Cannon Research Institute Nashville. Looking forward to his leadership and vision for cancer at BMS.

1

Navneet Majhail @bldcancerdoc.bsky.social · Jun 1

Impactful @ascocancer.bsky.social @theaacr.bsky.social session on innovations and access challenges for gene therapy. Dr Frangoul from Sarah Cannon Cancer Network/SCRI shared experience with clinical trials of Exa-cel. Jimi Olaghere shared experience as patient #16 on a trial. #ASCO25

1 4

Navneet Majhail @bldcancerdoc.bsky.social · Jun 1

@daxmd.bsky.social presents on multi-cancer early detection at #ASCO25: Highlights positive predictive value & sensitivity of reflex ctDNA methylation MCED for several cancer types in individuals with obesity. With its footprint in 20 states, Sarah Cannon Cancer Network is a pioneer in MCED studies.

1

Navneet Majhail @bldcancerdoc.bsky.social · May 30

Grateful for Sarah Cannon Research Institute colleagues all over the country who work hard and collaborate to advance cancer therapeutics. Learn more about #SCRI research that is being presented at #ASCO25 #ASCO2025 www.scri.com/asco/

1 5

Navneet Majhail @bldcancerdoc.bsky.social · May 29

👋 or 👍 if you are attending #ASCO25

2 3

Navneet Majhail @bldcancerdoc.bsky.social · May 27

Intermediate-dose posttransplantation cyclophosphamide for myeloablative HLA-haploidentical bone marrow transplantation @bloodadvances.bsky.social

ashpublications.org/bloodadvance...

Navneet Majhail @bldcancerdoc.bsky.social · May 20

I am in profound awe of the closeted prostate cancer experts who have emerged on social media over the last 24-48 hrs!

Navneet Majhail @bldcancerdoc.bsky.social · May 14

Congratulations to Malini and you #ProudDad!

1

Navneet Majhail @bldcancerdoc.bsky.social · May 9

Hey regular CAR-T 🚗 , armored #CARTcell 🏎️ has entered the room!
Enhanced CAR T-Cell Therapy for Lymphoma after Previous Failure | New England Journal of Medicine www.nejm.org/doi/full/10....

Enhanced CAR T-Cell Therapy for Lymphoma after Previous Failure | NEJM

Chimeric antigen receptor (CAR) T cells targeting CD19 have transformed the treatment of B-cell cancers, but many patients do not have long-term remission. We designed an anti-CD19 enhanced (armore...

www.nejm.org

1

Reposted by Navneet Majhail

ASTCT @astct.bsky.social · May 6

Applications are open for the 2026 International Trainee Observership Program. One international trainee from a low/mid-income country will participate in 4-week-long observership at the @uofcahealth.bsky.social.

📆 Deadline to apply: Friday, June 13
ow.ly/Ih0650VK0vn #MedSky #HCT #celltherapy

2 1

Navneet Majhail @bldcancerdoc.bsky.social · May 4

Happy #StarWarsDay

#MayThe4thBeWithYou

a picture of yoda from star wars with the words `` may the fourth be with you '' written on it .

ALT: a picture of yoda from star wars with the words `` may the fourth be with you '' written on it .

media.tenor.com

1

Navneet Majhail @bldcancerdoc.bsky.social · Apr 28

Congrats to Dr Stephen Strickland from Sarah Cannon Research Institute at TriStar Centennial Medical Center, Nashville for presenting first-in-human results of SENTI-202 (CD33/FLT3 off-the-shelf CAR NK #celltherapy) in heme malignancies/AML #AACR25
www.aacr.org/about-the-aa...

Off-the-shelf CAR Natural Killer Cell Therapy with Logic Gates Elicits Complete Remissions in Relapsed or Refractory Blood Cancers

Several patients with AML, who were treated with SENTI-202 experienced a complete remission after not responding to or having relapsed following prior treatments, according to results presented at the...

www.aacr.org

1 3

Navneet Majhail @bldcancerdoc.bsky.social · Apr 28

Medicine Spares Cancer Patients From Grisly Surgeries and Harsh Therapies www.nytimes.com/2025/04/27/h...

Immunotherapy Drug Spares Cancer Patients From Grisly Surgeries and Harsh Therapies

For a limited group of cancer patients who have solid tumors in the stomach, rectum, esophagus and other organs, an immunotherapy trial offered stunning results.

www.nytimes.com

Navneet Majhail @bldcancerdoc.bsky.social · Apr 19

🙏 for sharing @jameabraham.bsky.social - we share our learnings from Sarah Cannon Transplant and Cellular Therapy Network outpatient #CARTcell program (200+ patients treated in 2024)

Jame Abraham, MD, FACP @jameabraham.bsky.social · Apr 19

Excellent review article by @bldcancerdoc.bsky.social Outpatient Administration of Chimeric Antigen Receptor T-Cell Therapy Using Remote Patient Monitoring | JCO Oncology Practice ascopubs.org/doi/10.1200/... @acochran12733.bsky.social @oncoalert.bsky.social

2 2

Navneet Majhail @bldcancerdoc.bsky.social · Apr 15

Getting a lot of questions from our immunocompromised transplant/#CARTcell patients about measles vaccination with the recent uptick in outbreaks across the US; Resurfacing 2019 @astct.bsky.social guideline by @pergamic.bsky.social and colleagues www.astctjournal.org/article/S108...

Preventing Measles in Immunosuppressed Cancer and Hematopoietic Cell Transplantation Patients: A Position Statement by the American Society for Transplantation and Cellular Therapy

Until recently, measles exposures were relatively rare and so, consequently, were an afterthought for cancer patients and/or blood and marrow transplant recipients and their providers. Declines in mea...

www.astctjournal.org

2 3

Navneet Majhail @bldcancerdoc.bsky.social · Apr 15

That is a 50% success rate - pretty high for academic medicine! 😀

1

Navneet Majhail @bldcancerdoc.bsky.social · Apr 12

Had a great 1 1/2 days with new/emerging transplant and cellular therapy leaders at @astct.bsky.social Leadership Course; future of transplant and cell therapy is strong in the hands of our very talented young physician and administrative leaders

7

Navneet Majhail @bldcancerdoc.bsky.social · Apr 11

Foundation for the Accreditation of Cellular Therapy is organizing a community #CART working group to facilitate broader utilization of its accreditation standards for cell therapies - important step towards providing high-quality care to patients in the community factglobal.org/education-an...

Press Release

PRESS RELEASE OMAHA, Neb. - The Foundation for the Accreditation of Cellular Therapy (FACT) is announcing the formation of a ‘Community CAR T Working Group’ (working group) to discuss and propose cl...

factglobal.org

1 3

Navneet Majhail @bldcancerdoc.bsky.social · Apr 7

Dr David Johnson reprises 7 dictums for oncologists on what NOT to do for grand rounds:
- Microscopic mayhem
- TNM torture
- Mechanism of action meltdown
- Dosage deadlock
- Criteria catatonia
- Kaplan Meier killer
- Lymph node lobotomy
@ascocancer.bsky.social JOP ascopubs.org/doi/10.1200/...

An Oncologist's Guide to Ensuring Your First Medical Grand Rounds Will Be Your Last | JCO Oncology Practice

ascopubs.org

1

Navneet Majhail @bldcancerdoc.bsky.social · Apr 6

Academic Writing: Who is the Audience and What is the Message? Dr Weisdorf challenges us to consider: Which papers stated something new? Which challenged existing dogma or changed the field? Which were really important over time? @astct.bsky.social www.astctjournal.org/article/S266...

Academic Writing: Who is the Audience and What is the Message?

“The Secret is Comprised in Three Words–Work, Finish, Publish”Michael Faraday

www.astctjournal.org

1 3

Navneet Majhail @bldcancerdoc.bsky.social · Mar 31

Congratulations Gunjan (PS: @drmiguelperales.bsky.social have her join @bsky.app 🙏)

1

Navneet Majhail @bldcancerdoc.bsky.social · Mar 29

Huge loss for the cell and gene therapy community. Dr Marks had been at the forefront of innovating US’s regulatory framework to ensure access to these transformative therapies.

Matthew Herper @matthewherper.bsky.social · Mar 29

Our story on Marks’s ouster has been updated with a lot of comment and context www.statnews.com/2025/03/28/f...

Peter Marks, FDA’s top vaccine regulator, forced out

Top FDA official Peter Marks was forced to resign as the director of the Center for Biologics Evaluation and Research.

www.statnews.com

5

Navneet Majhail @bldcancerdoc.bsky.social · Mar 26

Is that 1/10 centers that already offer cell therapy? We onboard new CART companies and products all the time - would love to hear what the discussion was around why centers who can do this are not getting on board with the TCR product for synovial sarcoma.

1 1